UNICA IRIS Institutional Research Information System

ONALI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 55.700
NA - Nord America 1.806
AS - Asia 222
SA - Sud America 7
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 57.740
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 55.276
US - Stati Uniti d'America 1.801
SE - Svezia 224
CN - Cina 86
FI - Finlandia 69
SG - Singapore 69
DE - Germania 58
VN - Vietnam 52
GB - Regno Unito 32
FR - Francia 7
BR - Brasile 6
CA - Canada 5
GR - Grecia 5
IE - Irlanda 5
IN - India 5
CZ - Repubblica Ceca 4
KR - Corea 4
AT - Austria 3
BE - Belgio 3
ES - Italia 3
HU - Ungheria 3
BD - Bangladesh 2
EU - Europa 2
HK - Hong Kong 2
NZ - Nuova Zelanda 2
UA - Ucraina 2
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
LU - Lussemburgo 1
MK - Macedonia 1
NL - Olanda 1
RS - Serbia 1
Totale 57.740
Salva come PNG Salva come JPEG
Città #
Cagliari 55.064
Ashburn 380
Fairfield 276
Nyköping 204
Uta 141
Seattle 114
Wilmington 114
Chandler 105
Woodbridge 104
Cambridge 102
Houston 101
Helsinki 69
Dong Ket 52
Boston 49
New York 46
Redwood City 46
Ann Arbor 35
Boardman 34
Rome 27
Singapore 24
San Diego 20
London 15
Beijing 13
Shanghai 13
Jacksonville 9
Los Angeles 9
Mountain View 8
Nanjing 8
Atlanta 5
Jiaxing 5
Munich 5
Redmond 5
Brno 4
Dearborn 4
Kilburn 4
Norwalk 4
Seoul 4
Stockholm 4
Chiswick 3
Delhi 3
Florence 3
Garden City 3
Guangzhou 3
Patras 3
Vienna 3
Wuhan 3
Abergavenny 2
Acton 2
Anqing 2
Cedar Knolls 2
Churriana de la Vega 2
Cormano 2
Falls Church 2
Fiesole 2
Hong Kong 2
Isernia 2
Islington 2
Krefeld 2
Kunming 2
Merksem 2
Milan 2
Montecassiano 2
Montreal 2
Nanchang 2
Paris 2
Rende 2
Rockville 2
Sestu 2
Stony Brook 2
Szeged 2
Torino 2
Toronto 2
Ussana 2
Venice 2
Washington 2
Athens 1
Aubers 1
Auckland 1
Belgrade 1
Berkeley 1
Borås 1
Bracke 1
Brussels 1
Changsha 1
Chizhou 1
Collegeville 1
Córdoba 1
Dalian 1
Douglas 1
Dublin 1
Encino 1
Enola 1
Frankfurt am Main 1
Geislingen an der Steige 1
Haikou 1
Harringay 1
Hebei 1
Hefei 1
Henderson 1
Jinan 1
Totale 57.333
Salva come PNG Salva come JPEG
Nome #
IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame 8.827
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab 1.868
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors 1.854
Colonic phenotype of the ileum in Crohn's disease: A prospective study before and after ileocolonic resection 1.821
Ileal lesions in patients with ulcerative colitis after ileo-rectal anastomosis: Relationship with colonic metaplasia 1.722
Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease 1.485
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 1.421
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 1.392
Response Assessed by Ultrasonography as Target of Biological Treatment for Crohn's Disease 1.387
Steroid-free remission and closure of recto-vaginal fistula using adalimumab in a Crohn's disease patient naïve to anti-tumour necrosis factor alpha antibodies 1.368
The Resolution of Intestinal Inflammation: The Peace-Keeper's Perspective 1.319
Cancer and immunomodulators in inflammatory bowel diseases 1.221
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease 1.182
A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn's disease 1.157
Small bowel capsule endoscopy vs conventional techniques in patients with symptoms highly compatible with Crohn's Disease 1.045
Psoriasis phenotype in inflammatory bowel disease: A case-control prospective study 1.041
Adalimumab in active ulcerative colitis: A "real-life" observational study 1.041
Endoscopic vs ultrasonographic findings related to Crohn's Disease recurrence: A prospective longitudinal study at 3 years 1.025
Anti-TNF-alpha treatments and obstructive symptoms in Crohn's Disease: A prospective study 996
Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis 983
The Italian clinical experience with adalimumab in Crohn's disease: Eleven clinical cases 915
A novel Smad7 genetic variant mapping on the genomic region targeted by Mongersen is associated with Crohn's disease 911
Early post-operative endoscopic recurrence in Crohn's disease patients: Data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort 862
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 861
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy 819
Tumor infiltrating regulatory t cells in sporadic and colitis-associated colorectal cancer: The red little riding hood and the wolf 804
Measuring disease activity in Crohn's disease 777
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 763
Long-term safety of Infliximab for the treatment of inflammatory bowel disease: Does blocking TNFα reduce colitis-associated colorectal carcinogenesis? 738
TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in Inflammatory bowel disease 736
Post-operative recurrence of Crohn's disease: A prospective study at 5 years 722
Female reproductive health and inflammatory bowel disease: A practice-based review 722
Laparoscopic versus open ileo-colonic resection in crohn's disease: Short- and long-term results from a prospective longitudinal study 713
GPR120/FFAR4: A Potential New Therapeutic Target for Inflammatory Bowel Disease 709
Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trial 701
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 657
Efficacy and safety of infliximab and adalimumab in Crohn's disease: A single centre study 654
Comparative Effectiveness Research: A Roadmap to Sail the Seas of IBD Therapies 641
A Pharmacological Batch of Mongersen that Downregulates Smad7 is Effective as Induction Therapy in Active Crohn’s Disease: A Phase II, Open-Label Study 641
Cancer in Crohn's disease patients treated with infliximab: A long-term multicenter matched pair study 602
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 578
Development of a numerical index quantitating small bowel damage as detected by ultrasonography in Crohn's disease 571
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 570
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 566
A family study of asymptomatic small bowel Crohn's disease 549
Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: A single-center cohort study 543
Frequency, pattern, and risk factors of postoperative recurrence of Crohn's disease after resection different from ileo-colonic 525
Immune system and gut microbiota senescence in elderly IBD patients 501
Wireless capsule endoscopy and proximal small bowel lesions in Crohn's disease 499
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study 487
Small intestine contrast ultrasonography vs computed tomography enteroclysis for assessing ileal Crohn's disease 478
Accuracy of small-intestine contrast ultrasonography, compared with computed tomography enteroclysis, in characterizing lesions in patients with Crohn's disease 476
Frequency and pattern of endoscopic recurrence in Crohn's disease patients with ileocolonic resection using a laparoscopic versus laparotomic approach: A prospective longitudinal study 462
Non-invasive techniques for assessing postoperative recurrence in Crohn's disease 427
Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn's disease 400
Severity of postoperative recurrence in Crohn's disease: Correlation between endoscopic and sonographic findings 378
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study 339
Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative review 234
Multiple Orocutaneous Extraintestinal Manifestations in Ulcerative Colitis Patient: Complete Response to Ustekinumab 215
Totale 57.901
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.935
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020682 0 0 3 7 171 204 124 32 41 35 20 45
2020/20213.250 60 82 83 639 831 313 107 248 78 120 126 563
2021/20225.351 220 367 306 237 377 498 188 351 646 570 934 657
2022/20238.657 544 1.071 1.175 529 725 1.276 454 733 461 543 738 408
2023/20247.747 399 352 293 492 633 1.533 953 824 395 528 635 710
2024/202532.159 15.737 12.943 3.479 0 0 0 0 0 0 0 0 0
Totale 57.901